Medium materiality6/10
Entrada Therapeutics price target raised to $11 from $10 at Roth Capital
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Roth Capital raises TRDA PT to $11 from $10; current price $7.67.
- PT raised to $11; current price $7.67; Roth Capital
Key facts
- 01
Target: $11
- 02
Posted price: $7.67
- 03
Analyst firm: Roth Capital
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.